DERM 4.68 (+0.65%)
US48115J1097Drug ManufacturersDrug Manufacturers - Specialty & Generic

Journey Medical (DERM) Financial Metrics

This table shows a selected set of financial data points of Journey Medical (DERM). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.21 0 -27.26 105.02M -0.04 79.18M 240K 5.25M -3.85M 27.44M
2022 -1.69 0 -1.14 33.66M -0.29 73.67M -33.53M -23.09M -29.63M 32M
2021 -4.32 0 -1.25 54.82M -0.59 63.13M -12.18M -22.78M -43.99M 49.08M
2020 0.58 0 0 0 0.12 44.53M 3.93M 9.37M 5.28M 8.25M
2019 0.22 0 0 0 0.02 34.92M 6.62M 6.52M 3.63M 4.8M
2018 -5.27 0 0 0 -0.49 42.34M -269.71M -205.54M -221.54M 104.98M
2017 -7.48 0 0 0 -0.69 4.54M -184.24M -294.78M -303.26M 295.92M
2016 -2.7 0 0 0 -0.33 22.59M -74.86M -87.42M -89.08M 41.79M
2015 -2.93 0 0 0 -0.39 7.3M -48.64M -78.8M -78.4M 107.24M
2014 -4.96 0 0 0 0 7.3M -31.56M -31.64M -31.88M 55.36M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.